As shown in Table 1, our research identified 7 human studies that examined the association of TRAF2 (1 study), TRAF4 (3 studies), and TRAF6 (3 studies) with survival rate in breast cancer patients (719 patients). Here, TRAF2 is linked to breast carcinoma.